Arcus Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Arcus Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2024.
  • Arcus Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$94M, a 16% decline year-over-year.
  • Arcus Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$283M, a 7.82% increase year-over-year.
  • Arcus Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$283M, a 7.82% increase from 2023.
  • Arcus Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$307M, a 15% decline from 2022.
  • Arcus Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$267M, a 604% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$283M +$24M +7.82% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$307M -$40M -15% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$267M -$320M -604% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 $53M +$176M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$123M -$38.3M -45.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$84.7M -$35.1M -70.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$49.6M +$3.49M +6.57% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$53.1M -$35.1M -195% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-05
2016 -$18M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.